Abstract

Objective To explore the effect of pharmacological preconditioning wtith low-dose FK506 reducing subsequent ischemia-reperfusion injury in rabbit knee joint and to explore the possible mechanism ofthat. Methods Twenty four animal model of allograft heterootopic knee joint were established and divided randonly into three groups: IR group (lschemia-reperfusion group), FK506 group (FK506 preconditioning group) and ST group( Sham control group). Vessels were clamped for 1 hour, and then grafts received reperfusion. Tissues(for example muscles tissues) of pro-ischemia and reperfusion after 12 hours were obtained,and they were observed by microscope and electron microscope and were analysised with reverse transcription polymerase chain reaction(RT-PCR), Western Blot, DNA ladder, flow cytometer. Moreover, the contents of MDA, NO and SOD in these tissues were examined by spectrophotometer. Results As a result, we observed disoranized tissues and swollen cells in IR groups but trenchant tissues and intact cells in FK506 groups by microscope, vacuolated and tumid mitochondrion in IR groups but non-vacuolated and intact that in FKS06groups. With FK506 preconidtioning, the contents MDA and NO were distinctly reduced but significant raisedin FK506 group. Compared with IR group, DNA ladder of FK506 group were weakly, and apoptotic ractes reduce from 20% to 10% and the expression of TNF, IL-1, Fas and FasL mRNA obviously down-regulated. At the same time, expression of HSP70 significantly up-regulated on protein and mRNA levels with RT-PCR andWestern blotting analysis in FK506 group. Conclusion Pharmacological preconditioning with low-dose FK506 (0. 3mg/kg) can induce tolerance of ischemia-reperfusion injury in rabbit allograft knee joint. Over-expression of HSP70 may be key factor of that. Key words: Allograft; Knee joint Ischemia-reperfusion injury; Heat shock protein 70; Taerolimus(FK506)

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.